(Q36527206)

English

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial

scientific article published on 13 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Efficiency and effectiveness of the use of an acenocoumarol pharmacogenetic dosing algorithm versus usual care in patients with venous thromboembolic disease initiating oral anticoagulation: study protocol for a randomized controlled trial (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

anticoagulation

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Antonio J Carcas

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Alberto M Borobia

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Marta Velasco

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Francisco Abad-Santos

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Manuel Quintana Díaz

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Carmen Fernández-Capitán

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Nuria Ruiz-Giménez

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Olga Madridano

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Pilar Llamas Sillero

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PGX-ACE Spanish Investigators Group

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

publication date

13 December 2012

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

13

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

239

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Integration of genetic, clinical, and INR data to refine warfarin dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Pharmacogenetics of oral anticoagulants: a basis for dose individualization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

CYP4F2 genetic variant alters required warfarin dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Use of genetic and nongenetic factors in warfarin dosing algorithms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Evaluation of genetic factors for warfarin dose prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Natural history of venous thromboembolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

A method for estimating the probability of adverse drug reactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

30 September 2017

A multiplex assay to detect variations in the CYP2C9, VKORC1, CYP4F2 and APOE genes involved in acenocoumarol metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

28 June 2018

A method to determine the optimal intensity of oral anticoagulant therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

28 June 2018

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

28 June 2018

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Genotypes associated with reduced activity of VKORC1 and CYP2C9 and their modification of acenocoumarol anticoagulation during the initial treatment period

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

A genome-wide association study of acenocoumarol maintenance dosage.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-13-239

21 January 2018

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

21 September 2018

Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

21 September 2018

Venous thromboembolism in Spain. Comparison between an administrative database and the RIETE registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543328

21 October 2018

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23237631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23237631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent venous thromboembolism during coumarin therapy. Data from the computerised registry of patients with venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/23237631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-13-239

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

release_hpw4pkdoknhddd53wi2ijtynky

1 reference

https://api.fatcat.wiki/v0/release/hpw4pkdoknhddd53wi2ijtynky

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36527206&oldid=2199000923"